EVERYTHING ABOUT API IN PHARMACEUTICAL MANUFACTURING

“The present problem has exposed some structural weaknesses while in the EU’s medicines offer chain along with a higher dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She advised that supply chain issues be resolved within an EU pharmaceutical approach anticipated being launched by the top of your 1